Document is current

Any future updates will be listed below

10 Performance of SLEDAI-2K Responder Index-50 in a Randomized Placebo-Controlled Trial with Ustekinumab (UST) in Systemic Lupus Erythematosus

Crossref DOI link: https://doi.org/10.1136/lupus-2019-lsm.10

Published Online: 2019-04-05

Published Print: 2019-04

Update policy: https://doi.org/10.1136/crossmarkpolicy

About CrossMark